cf33-hnis
imugene
['cf33-hnis', 'tnbc', 'breast']
#cedarssinaicancer at #aacr23. dr. yuan yuan is senior author on the poster hnis imaging data from a first-in-human trial of the oncolytic virus cf33-hnis-antipd-l1 in patients with triple negative #breastcancer presented at 6:00am pt. #tnbc 
Cedars-Sinai Cancer, ranked #9 in the nation in 2021 by U.S. News & World Report.